# OnCo record viale-a (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/viale-a/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "viale-a", "NCT02993523" ;
  schema:name "VIALE-A"@en ;
  schema:description "The trial that gave older AML patients a real treatment: adding venetoclax to azacitidine doubled remission rates and extended survival."@en ;
  schema:url <https://onco.cc/trials/viale-a/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02993523>, <https://www.nejm.org/doi/full/10.1056/NEJMoa2012971> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2017-02-02" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/aml-older-unfit/> ;
  onco:technologies <https://onco.cc/technologies/bcl2-inhibitors/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/bcl2/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/azacitidine/> ;
  onco:companies <https://onco.cc/companies/abbvie/>, <https://onco.cc/companies/roche-genentech/> ;
  onco:pathways <https://onco.cc/pathways/apoptosis-bcl2/> ;
  onco:terms <https://onco.cc/terms/tumor-lysis-syndrome/> ;
  onco:people <https://onco.cc/people/courtney-dinardo/> .